{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:29:03Z","timestamp":1787891343354,"version":"build-2784847793"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04130-7","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:17:17Z","timestamp":1742455037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study on risk factors and associated drug related problems in patients with stroke"],"prefix":"10.1186","volume":"25","author":[{"given":"Tulsi","family":"Bhusal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Bista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojeena Koju","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"9","key":"4130_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.mpmed.2020.06.002","volume":"48","author":"SJX Murphy","year":"2020","unstructured":"Murphy SJX, Werring DJ. Stroke: causes and clinical features. Medicine. 2020;48(9):561\u20136.","journal-title":"Medicine"},{"issue":"1","key":"4130_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0141076816680121","volume":"110","author":"AP Coupland","year":"2017","unstructured":"Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110(1):9\u201312.","journal-title":"J R Soc Med"},{"issue":"4","key":"4130_CR3","first-page":"421","volume":"16","author":"JP Frizzell","year":"2005","unstructured":"Frizzell JP. Acute stroke: pathophysiology, diagnosis, and treatment. AACN Adv Crit Care. 2005;16(4):421\u201340.","journal-title":"AACN Adv Crit Care"},{"issue":"1","key":"4130_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rcl.2010.07.011","volume":"49","author":"SD Smith","year":"2011","unstructured":"Smith SD, Eskey CJ. Hemorrhagic stroke. Radiol Clin North Am. 2011;49(1):27\u201345.","journal-title":"Radiol Clin North Am"},{"issue":"02","key":"4130_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0038-1649503","volume":"38","author":"M Katan","year":"2018","unstructured":"Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(02):208\u201311.","journal-title":"Semin Neurol"},{"issue":"6","key":"4130_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1056\/NEJMcp072057","volume":"357","author":"HB Van Der Worp","year":"2007","unstructured":"Van Der Worp HB, Van Gijn J. Acute ischemic stroke. N Engl J Med. 2007;357(6):572\u20139.","journal-title":"N Engl J Med"},{"issue":"24","key":"4130_CR7","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1001\/jama.296.24.2939","volume":"296","author":"R Carandang","year":"2006","unstructured":"Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, et al. Trends in incidence, lifetime risk, severity, and 30-Day mortality of stroke over the past 50 years. JAMA. 2006;296(24):2939\u201346.","journal-title":"JAMA"},{"issue":"1","key":"4130_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3126\/njn.v15i1.20021","volume":"15","author":"A Thapa","year":"2018","unstructured":"Thapa A, Kc B, Shakya B, Yadav DK, Lama K, Shrestha R. Changing epidemiology of stroke in Nepalese population. Nep J Neurosci. 2018;15(1):10\u20138.","journal-title":"Nep J Neurosci"},{"issue":"5","key":"4130_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"GBD 2016 Stroke Collaborators","year":"2019","unstructured":"GBD 2016 Stroke Collaborators. Global, regional, and National burden of stroke, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439\u201358.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4130_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2008-1040896","volume":"18","author":"MS Elkind","year":"1998","unstructured":"Elkind MS, Sacco RL. Stroke risk factors and stroke prevention. Semin Neurol. 1998;18(4):429\u201340.","journal-title":"Semin Neurol"},{"issue":"9","key":"4130_CR11","doi-asserted-by":"publisher","first-page":"e015758","DOI":"10.1136\/bmjopen-2016-015758","volume":"7","author":"ZN Zhang, Guo","year":"2017","unstructured":"Zhang, Guo ZN, Wu YH, Liu HY, Luo Y, Sun MS, et al. Prevalence of stroke and associated risk factors: a population based cross sectional study from Northeast China. BMJ Open. 2017;7(9):e015758.","journal-title":"BMJ Open"},{"issue":"3","key":"4130_CR12","first-page":"533","volume":"47","author":"CD Hepler","year":"1990","unstructured":"Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533\u201343.","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"4130_CR13","first-page":"2796","volume":"21","author":"U Acharya","year":"2023","unstructured":"Acharya U, Shankar PR, Palaian S, Dangol R, Jha N, Thakur A. Pattern of drug therapy related problems encountered by clinical pharmacists in a critical care setting in Nepal. Pharm Pract. 2023;21(2):2796.","journal-title":"Pharm Pract"},{"key":"4130_CR14","first-page":"100528","volume":"16","author":"RB Thapa","year":"2024","unstructured":"Thapa RB, Dahal P, Karki S, Mainali UK. Exploration of drug therapy related problems in a general medicine ward of a tertiary care hospital of Eastern Nepal. Explor Res Clin Soc Pharm. 2024;16:100528.","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"4130_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12877-020-1413-7","volume":"20","author":"BY Hailu","year":"2020","unstructured":"Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):13.","journal-title":"BMC Geriatr"},{"issue":"9","key":"4130_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-004-0830-4","volume":"60","author":"HS Blix","year":"2004","unstructured":"Blix HS, Viktil KK, Reikvam \u00c5, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"4130_CR17","unstructured":"Gayathri B, Divasish LE, Soni M, Hup GK, Prasath KH. DRUG RELATED PROBLEMS: A SYSTEMIC LITERATURE REVIEW. 2018."},{"issue":"5","key":"4130_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"key":"4130_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11648\/j.cmr.20150406.13","volume":"4","author":"E Greffie","year":"2015","unstructured":"Greffie E. Risk factors, clinical pattern and outcome of stroke in a referral hospital, Northwest Ethiopia. Clin Med Res. 2015;4:182.","journal-title":"Clin Med Res"},{"key":"4130_CR20","doi-asserted-by":"crossref","unstructured":"Erkabu S, Agedie Y, Mihretu D, Semere A, Mulugeta Y. Ischemic and hemorrhagic stroke in Bahir Dar, Ethiopia: A retrospective Hospital-Based study. J Stroke Cerebrovasc Dis. 2018;27.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.050"},{"key":"4130_CR21","doi-asserted-by":"crossref","unstructured":"Alharbi M, Alharbi A, Alamri M, Alharthi A, Alqerafi A, Alharbi M. Ischemic stroke: prevalence of modifiable risk factors in the Saudi population. IJMDC. 2019;601\u20133.","DOI":"10.24911\/IJMDC.51-1548376707"},{"key":"4130_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3126\/kumj.v9i4.6337","volume":"9","author":"A Maskey","year":"2011","unstructured":"Maskey A, Parajuli M, Kohli S. A study of risk factors of stroke in patients admitted in manipal teaching hospital, Pokhara. Kathmandu Univ Med J. 2011;9:244\u20137.","journal-title":"Kathmandu Univ Med J"},{"issue":"1","key":"4130_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3126\/jbsfn.v1i1.32222","volume":"1","author":"R Luitel","year":"2020","unstructured":"Luitel R, Dhital S, Paudel SS, Bhattarai S. Socio-demographic characteristics of ischemic stroke patients in a tertiary care hospital of Nepal. J Brain Spine Fdn Nep. 2020;1(1):16\u20139.","journal-title":"J Brain Spine Fdn Nep"},{"issue":"7","key":"4130_CR24","first-page":"e63640","volume":"16","author":"S Shivde","year":"2024","unstructured":"Shivde S, Badachi S, Deepalam S, Nadig R, Huddar A, Mathew T, et al. Risk factors and stroke subtyping in young adults: A study from a tertiary care hospital in South India. Cureus. 2024;16(7):e63640.","journal-title":"Cureus"},{"key":"4130_CR25","doi-asserted-by":"crossref","unstructured":"Sapkota S, Chhetri H, Sharma R. Study on risk factors, presentation and management of stroke in a tertiary care hospital. Janaki Med Coll J Med Sci. 2014;2.","DOI":"10.3126\/jmcjms.v2i1.11394"},{"issue":"1","key":"4130_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12883-019-1409-0","volume":"19","author":"G Fekadu","year":"2019","unstructured":"Fekadu G, Chelkeba L, Kebede A. Risk factors, clinical presentations and predictors of stroke among adult patients admitted to stroke unit of Jimma university medical center, South West Ethiopia: prospective observational study. BMC Neurol. 2019;19(1):187.","journal-title":"BMC Neurol"},{"key":"4130_CR27","unstructured":"Kamal A, Aslam S, Khattak S. Frequency of Risk Factors in Stroke Patients admitted to DHQ Teaching Hospital, D.I.Khan. Gomal Journal of Medical Sciences [Internet]. 2010 Dec 31 [cited 2024 Aug 14];8(2). Available from: https:\/\/www.gjms.com.pk\/index.php\/journal\/article\/view\/348"},{"issue":"7","key":"4130_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.22159\/ijpps.2017v9i7.14189","volume":"9","author":"E Mathew","year":"2017","unstructured":"Mathew E, Karanath CC, A PROSPECTIVE OBSERVATIONAL STUDY PMRS, ON PRESCRIBING TRENDS AND ADVERSE DRUG REACTIONS IN STROKE PATIENTS. Int J Pharm Pharm Sci. 2017;9(7):25.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"6","key":"4130_CR29","doi-asserted-by":"publisher","first-page":"6715725","DOI":"10.21037\/apm-21-1272","volume":"10","author":"A Feng","year":"2021","unstructured":"Feng A, Wang W, Du C, He M. A systematic review and meta-analysis of early diagnosis and treatment of hypertensive stroke under calcium channel blockers. Annals Palliat Med. 2021;10(6):6715725\u20136725.","journal-title":"Annals Palliat Med"},{"issue":"6","key":"4130_CR30","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1161\/STROKEAHA.120.033033","volume":"52","author":"K Bhatia","year":"2021","unstructured":"Bhatia K, Jain V, Aggarwal D, Vaduganathan M, Arora S, Hussain Z, et al. Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack: Meta-Analysis of randomized controlled trials. Stroke. 2021;52(6):e217\u201323.","journal-title":"Stroke"},{"issue":"25","key":"4130_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.121.053782","volume":"143","author":"G Trifan","year":"2021","unstructured":"Trifan G, Gorelick PB, Testai FD. Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: systematic review and Meta-Analysis of randomized controlled clinical trials. Circulation. 2021;143(25):2441\u201353.","journal-title":"Circulation"},{"issue":"1","key":"4130_CR32","first-page":"127","volume":"7","author":"M Kulshrestha","year":"2013","unstructured":"Kulshrestha M, Vidyanand. An analysis of the risk factors and the outcomes of cerebrovascular diseases in Northern India. J Clin Diagn Res. 2013;7(1):127\u201331.","journal-title":"J Clin Diagn Res"},{"key":"4130_CR33","unstructured":"Sahani B, Mandal RK. Demographic profile and risk factors of stroke patients in a tertiary care centre of Nepal. 2021;6:668\u201391."},{"issue":"1","key":"4130_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/2277-9175.164011","volume":"4","author":"K Shravani","year":"2015","unstructured":"Shravani K, Parmar MY, Macharla R, Mateti UV, Martha S. Risk factor assessment of stroke and its awareness among stroke survivors: A prospective study. Adv Biomedical Res. 2015;4(1):187.","journal-title":"Adv Biomedical Res"},{"key":"4130_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.59779\/jiomnepal.364","volume":"30","author":"V Bhatt","year":"2008","unstructured":"Bhatt V, Parajuli N, Mainali N, Sigdel S, Aryal M, Hamal N, et al. Risk factors of stroke. J Inst Med. 2008;30:37\u201341.","journal-title":"J Inst Med"},{"issue":"1","key":"4130_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-023-03382-5","volume":"23","author":"R Paudel","year":"2023","unstructured":"Paudel R, Tunkl C, Shrestha S, Subedi RC, Adhikari A, Thapa L, et al. Stroke epidemiology and outcomes of stroke patients in Nepal: a systematic review and meta-analysis. BMC Neurol. 2023;23(1):1\u201312.","journal-title":"BMC Neurol"},{"issue":"2","key":"4130_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.22502\/jlmc.v4i2.91","volume":"4","author":"S Acharya","year":"2016","unstructured":"Acharya S, Tiwari A, Shakya RP. Clinico-radiological profile of stroke in Western Nepal. J Lumbini Med Coll. 2016;4(2):60\u20133.","journal-title":"J Lumbini Med Coll"},{"issue":"3","key":"4130_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.18203\/2320-6012.ijrms20170656","volume":"5","author":"T Subburaj","year":"2017","unstructured":"Subburaj T, Kumarasamy S, Velayudam S. Etiology and risk factors among young patients presenting with stroke in a tertiary care hospital in South India. Int J Res Med Sci. 2017;5(3):1027.","journal-title":"Int J Res Med Sci"},{"issue":"1","key":"4130_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3126\/egn.v2i1.27462","volume":"2","author":"B Jwarchan","year":"2020","unstructured":"Jwarchan B, Yogi N, Adhikari S, Bhandari P, Lalchan S. A study of prevalence and predictors of acute ischemic CVA patients admitted to manipal teaching hospital, Pokhara, Nepal. East Green Neurosurg. 2020;2(1):42\u20136.","journal-title":"East Green Neurosurg"},{"issue":"1","key":"4130_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3329\/fmcj.v11i1.30875","volume":"11","author":"R Saha","year":"2016","unstructured":"Saha R, Islam MSU, Hossain AM, Kabir MR, Mamun AA, Saha SK, et al. Clinical presentation and risk factors of stroke-A study of 100 hospitalized stroke patients in Bangladesh. Faridpur Med Coll J. 2016;11(1):23\u20135.","journal-title":"Faridpur Med Coll J"},{"key":"4130_CR41","doi-asserted-by":"crossref","unstructured":"Pokharel BR, Kharel G. Stroke in young Patients - A new trend in Nepalese perspective?? J Nutritional Disorders Therapy. 2015;05.","DOI":"10.4172\/2161-0509.S1-001"},{"key":"4130_CR42","unstructured":"Yadav R, Sah AK, Shah S, Shah A, Shah S, Yadav P. Study of risk factors in stroke in tertiary level hospital of Pokhara: A Cross-Sectional study. 2023;6(4)."},{"key":"4130_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ensci.2016.02.010","volume":"3","author":"SA Gebremariam","year":"2016","unstructured":"Gebremariam SA, Yang HS. Types, risk profiles, and outcomes of stroke patients in a tertiary teaching hospital in Northern Ethiopia. eNeurologicalSci. 2016;3:41\u20137.","journal-title":"eNeurologicalSci"},{"key":"4130_CR44","doi-asserted-by":"crossref","unstructured":"Zhang JT. P J, Y W, R A, G H. Total and high-density lipoprotein cholesterol and stroke risk. Stroke [Internet]. 2012 Jul [cited 2025 Feb 20];43(7). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22496337\/","DOI":"10.1161\/STROKEAHA.111.646778"},{"issue":"5suppl4","key":"4130_CR45","first-page":"S39","volume":"49","author":"RL Sacco","year":"1997","unstructured":"Sacco RL. Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology. 1997;49(5suppl4):S39\u201344.","journal-title":"Neurology"},{"issue":"3","key":"4130_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.26425","volume":"92","author":"CDL Johannesen","year":"2022","unstructured":"Johannesen CDL, Mortensen MB, Langsted A, Nordestgaard BG. ApoB and Non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk. Ann Neurol. 2022;92(3):379\u201389.","journal-title":"Ann Neurol"},{"key":"4130_CR47","unstructured":"Sorganvi V. RISK FACTORS FOR STROKE: A CASE CONTROL STUDY. 06."},{"key":"4130_CR48","unstructured":"Khan VE. Risk factors for stroke: A hospital based study. Pakistan J Med Sci. 2007;23."},{"issue":"14","key":"4130_CR49","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2174\/156802609789869628","volume":"9","author":"K Tziomalos","year":"2009","unstructured":"Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Dyslipidemia as a risk factor for ischemic stroke. Curr Top Med Chem. 2009;9(14):1291\u20137.","journal-title":"Curr Top Med Chem"},{"key":"4130_CR50","doi-asserted-by":"crossref","unstructured":"Mohammed PS, Laloo F, Madhur A, Robert R, Mathew B, ASSESSMENT OF DRUG RELATED PROBLEMS IN A TERTIARY CARE TEACHING HOSPITAL., INDIA. Asian J Pharm Clin Res. 2017;310\u20133.","DOI":"10.22159\/ajpcr.2017.v10i2.15678"},{"key":"4130_CR51","unstructured":"Seuma ATC, Ramesh J. A. Assessment of Drug Related Problems in Stroke Patients Admitted to a South Indian Tertiary Care Teaching Hospital. Indian Journal of Pharmacy Practice [Internet]. 2012 [cited 2024 Jul 16]; Available from: https:\/\/www.semanticscholar.org\/paper\/Assessment-of-Drug-Related-Problems-in-Stroke-to-a-A.T-Seuma\/dddce16c094cfb0e817a64583a06b1e25c0a401e"},{"issue":"2","key":"4130_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/01.HYP.0000177118.46049.e6","volume":"46","author":"CM Kim, Nam","year":"2005","unstructured":"Kim, Nam CM, Jee SH, Suh I. Comparison of blood Pressure\u2013Associated risk of intracerebral hemorrhage and subarachnoid hemorrhage. Hypertension. 2005;46(2):393\u20137.","journal-title":"Hypertension"},{"issue":"4","key":"4130_CR53","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s11096-020-01081-6","volume":"42","author":"Z Chen, Jin","year":"2020","unstructured":"Chen, Jin Z, Zhang P, Sun S, Li L, Liao Y. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China. Int J Clin Pharm. 2020;42(4):1237\u201341.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"4130_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40360-021-00530-w","volume":"22","author":"P Liu","year":"2021","unstructured":"Liu P, Li G, Han M, Zhang C. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China. BMC Pharmacol Toxicol. 2021;22(1):65.","journal-title":"BMC Pharmacol Toxicol"},{"key":"4130_CR55","first-page":"07","volume":"10","author":"A Sharma","year":"2018","unstructured":"Sharma A, Baldi A, Sharma DK. Assessment of drug-related problems among diabetes and cardiovascular disease patients in a tertiary care teaching hospital. Pharmaspire. 2018;10:07\u201312.","journal-title":"Pharmaspire"},{"key":"4130_CR56","unstructured":"Babu M, Swami A, Kilari V, Kakumani M, Vasantha S. ASSESSMENT OF DRUG RELATED PROBLEMS IN STROKE PATIENTS. 2021."},{"key":"4130_CR57","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1515\/med-2019-0093","volume":"14","author":"DZ Aleksic","year":"2019","unstructured":"Aleksic DZ, Jankovic SM, Mlosavljevic MN, Toncev GL, Miletic Drakulic SD, Stefanovic SM. Potential Drug-drug interactions in acute ischemic stroke patients at the neurological intensive care unit. Open Med (Wars). 2019;14:813\u201326.","journal-title":"Open Med (Wars)"},{"issue":"9","key":"4130_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.22159\/ajpcr.2016.v9s3.13651","volume":"9","author":"PKS Jith","year":"2016","unstructured":"Jith PKS, Kumar A, Joy CT JS, R SK, A PROSPECTIVE STUDY, OF DRUG\u2013DRUG INTERACTIONS AND ADVERSE DRUG REACTIONS AMONG STROKE PATIENTS IN A TERTIARY CARE HOSPITAL. Asian J Pharm Clin Res. 2016;9(9):100.","journal-title":"Asian J Pharm Clin Res"},{"issue":"12","key":"4130_CR59","doi-asserted-by":"publisher","first-page":"e066846","DOI":"10.1136\/bmjopen-2022-066846","volume":"12","author":"OV Kravchenko","year":"2022","unstructured":"Kravchenko OV, Boyce RD, Gomez-Lumbreras A, Kocis PT, Villa Zapata L, Tan M, et al. Drug\u2013drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case\u2013control study in the National COVID cohort collaborative (N3C). BMJ Open. 2022;12(12):e066846.","journal-title":"BMJ Open"},{"issue":"2","key":"4130_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/mtsm.mtsm_2_21","volume":"6","author":"AA Mohammed","year":"2022","unstructured":"Mohammed AA, Arbab AH, TAbdalla TMT. Assessment of risk factors and management of ischemic stroke at Ibrahim Malik teaching hospital in Khartoum, 2018. Matrix Sci Med. 2022;6(2):48.","journal-title":"Matrix Sci Med"},{"key":"4130_CR61","doi-asserted-by":"crossref","unstructured":"George GK, Sundaran S, Cp AA, Km M, Ph T, Gopalakrishnan A. STUDY OF DRUG-DRUG INTERACTION IN THE INPATIENTS OF A TERTIARY CARE HOSPITAL AT CALICUT. 2018;11(9).","DOI":"10.22159\/ajpcr.2018.v11i9.26152"},{"key":"4130_CR62","doi-asserted-by":"crossref","unstructured":"Hasan M, Yanis M, Hajri HN. Potential Drug-Related Problems in Ischemic Stroke Patients and Their Effect on Clinical Outcomes at RS X, East Jakarta, in 2019. Journal of Hunan University Natural Sciences [Internet]. 2023 [cited 2024 Aug 21];50(8). Available from: http:\/\/jonuns.com\/index.php\/journal\/article\/view\/1431","DOI":"10.55463\/issn.1674-2974.50.8.8"},{"key":"4130_CR63","first-page":"FC15","volume":"16","author":"A Johnson","year":"2022","unstructured":"Johnson A, Thomas A, Jose S, Mateti U, Kellarai A, Shetty S, et al. ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTION IN STROKE PATIENTS. J Clin Diagn Res. 2022;16:FC15\u201320.","journal-title":"J Clin Diagn Res"},{"key":"4130_CR64","unstructured":"Bose D, Muraraiah S, PATTERN & PREDICTORS OF DRUG-DRUG INTERACTIONS AMONG THE PATIENTS ADMITTED IN NEUROLOGY AT A TERTIARY CARE HOSPITAL.\u2013 A CROSS-SECTIONAL STUDY. Int J Pharm Sci Res. 2016."},{"key":"4130_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/DHPS.S436458","volume":"15","author":"RM Hamadouk","year":"2023","unstructured":"Hamadouk RM, Alshareif EM, Hamad HM, Yousef BA. The prevalence and severity of potential Drug\u2013Drug interactions in internal medicine ward at Soba teaching hospital. DHPS. 2023;15:149\u201357.","journal-title":"DHPS"},{"issue":"6","key":"4130_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/ejhpharm-2017-001272","volume":"25","author":"Y Bethi","year":"2018","unstructured":"Bethi Y, Shewade DG, Dutta TK, Gitanjali B. Prevalence and predictors of potential drug\u2013drug interactions in patients of internal medicine wards of a tertiary care hospital in India. Eur J Hosp Pharm. 2018;25(6):317\u201321.","journal-title":"Eur J Hosp Pharm"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04130-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T14:07:44Z","timestamp":1742479664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04130-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04130-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Committee of Annapurna Hospital, Kathmandu with approval reference number IRC-ANIAS-114-2023\/2024 before carrying out the study. All patients were given written informed consent. Patient information was kept confidential throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}